CVS HEALTH CORP

Discover how CVS Health’s 1.1 % rise and Nashville food‑security push are redefining its brand as a community health hub, not just a retailer.

CVS Health’s focus on GLP‑1 drugs, digital health and PBM pricing positions it for robust earnings growth amid a shifting pharmacy landscape.

CVS Health’s steady 0.35% rise to $94.75 reflects solid growth and a resilient market position, offering investors a blend of pharmacy retail and PBM expertise.